Page 1927 - Williams Hematology ( PDFDrive )

1902 Part XII: Hemostasis and Thrombosis Chapter 112: Platelet Morphology, Biochemistry, and Function 1903

1065. Douglas H, et al: Platelet membrane glycoprotein Ibalpha gene -5T/C Kozak sequence 1098. Dong JF, et al: The cytoplasmic domain of glycoprotein (GP) Ibalpha constrains the
polymorphism as an independent risk factor for the occurrence of coronary throm- lateral diffusion of the GP Ib-IX complex and modulates von Willebrand factor bind-
bosis. Heart 87(1):70–74, 2002. ing. Biochemistry 36(41):12421–12427, 1997.
1066. Jilma-Stohlawetz P, et al: Glycoprotein Ib polymorphisms influence platelet plug for- 1099. Delaney MK, et al: The role of Rac1 in glycoprotein Ib-IX-mediated signal transduc-
mation under high shear rates. Br J Haematol 120(4):652–655, 2003. tion and integrin activation. Arterioscler Thromb Vasc Biol 32(11):2761–2768, 2012.
1067. Kenny D, et al: Platelet glycoprotein Ib alpha receptor polymorphisms and recur- 1100. Estevez B, et al: LIM kinase-1 selectively promotes glycoprotein Ib-IX-mediated
rent ischaemic events in acute coronary syndrome patients. J Thromb Thrombolysis TXA2 synthesis, platelet activation, and thrombosis. Blood 121(22):4586–4594, 2013.
13(1):13–19, 2002. 1101. Munday AD, Berndt MC, Mitchell CA: Phosphoinositide 3-kinase forms a com-
1068. Meisel C, et al: Role of Kozak sequence polymorphism of platelet glycoprotein Ibalpha plex with platelet membrane glycoprotein Ib-IX-V complex and 14–3–3zeta. Blood
as a risk factor for coronary artery disease and catheter interventions. J Am Coll Car- 96(2):577–584, 2000.
diol 38(4):1023–1027, 2001. 1102. Falati S, Edmead CE, Poole AW: Glycoprotein Ib-V-IX, a receptor for von Willebrand
1069. Ozelo MC, et al: Platelet glycoprotein Ibα polymorphisms modulate the risk for myo- factor, couples physically and functionally to the Fc receptor γ-chain, Fyn, and Lyn to
cardial infarction. Thromb Haemost 92(2):384–386, 2004. activate human platelets. Blood 94(5):1648–1656, 1999.
1070. Rosenberg N, et al: Effects of platelet membrane glycoprotein polymorphisms on the 1103. Sullam PM, et al: Physical proximity and functional interplay of the glycoprotein
risk of myocardial infarction in young males. Isr Med Assoc J 4(6):411–414, 2002. Ib-IX-V complex and the Fc receptor FcgammaRIIA on the platelet plasma mem-
1071. Tsuji T, et al: The carbohydrate moiety of human platelet glycocalicin. J Biol Chem brane. J Biol Chem 273(9):5331–5336, 1998.
258(10):6335–6339, 1983. 1104. Watson SP, et al: The role of ITAM- and ITIM-coupled receptors in platelet activation
1072. Fox JEB, Aggerbeck LP, Berndt MC: Structure of the glycoprotein Ib-IX complex from by collagen. Thromb Haemost 86(1):276–288, 2001.
platelet membranes. J Biol Chem 263:4882–4890, 1988. 1105. Wu Y, et al: Role of Fc receptor gamma-chain in platelet glycoprotein Ib-mediated
1073. Solum NO, et al: Platelet glycocalicin: Its membrane association in solvent and aque- signaling. Blood 97(12):3836–3845, 2001.
ous media. Biochim Biophys Acta 597:235–246, 1990. 1106. Ozaki Y, Suzuki-Inoue K, Inoue O: Platelet receptors activated via mulitmerization:
1074. Coller BS, et al: Evidence that glycocalicin circulates in normal plasma. J Clin Invest Glycoprotein VI, GPIb-IX-V, and CLEC-2. J Thromb Haemost 11 Suppl 1:330–339,
73:794–799, 1984. 2013.
1075. Liang X, et al: Specific inhibition of ectodomain shedding of glycoprotein Ibalpha 1107. Blenner MA, Dong X, Springer TA: Structural basis of regulation of von Willebrand
by targeting its juxtamembrane shedding cleavage site. J Thromb Haemost 11(12): factor binding to glycoprotein Ib. J Biol Chem 289(9):5565–5579, 2014.
2155–2162, 2013. 1108. Dumas JJ, et al: Crystal structure of the wild-type von Willebrand factor A1-glycopro-
1076. Bergmeier W, et al: Tumor necrosis factor-alpha-converting enzyme (ADAM17) tein Ibalpha complex reveals conformation differences with a complex bearing von
mediates GPIbalpha shedding from platelets in vitro and in vivo. Circ Res 95(7): Willebrand disease mutations. J Biol Chem 279(22):23327–23334, 2004.
677–683, 2004. 1109. Huizinga EG, et al: Structures of glycoprotein Ibalpha and its complex with von Wille-
1077. Mo X, et al: Transmembrane and trans-subunit regulation of ectodomain shedding of brand factor A1 domain. Science 297(5584):1176–1179, 2002.
platelet glycoprotein Ibalpha. J Biol Chem 285(42):32096–32104, 2010. 1110. Uff S, et al: Crystal structure of the platelet glycoprotein Ib(alpha) N-terminal domain
1078. Wang Z, et al: The role of calpain in the regulation of ADAM17-dependent GPIbalpha reveals an unmasking mechanism for receptor activation. J Biol Chem 277(38):
ectodomain shedding. Arch Biochem Biophys 495(2):136–143, 2010. 35657–35663, 2002.
1079. Zhang P, et al: The role of intraplatelet reactive oxygen species in the regulation of 1111. Shen Y, et al: Leucine-rich repeats 2–4 (Leu60-Glu128) of platelet glycoprotein Ibal-
platelet glycoprotein Ibalpha ectodomain shedding. Thromb Res 132(6):696–701, 2013. pha regulate shear-dependent cell adhesion to von Willebrand factor. J Biol Chem
1080. Beer JH, Buchi L, Steiner B, Glycocalicin: A new assay—the normal plasma levels and 281(36):26419–26423, 2006.
its potential usefulness in selected diseases. Blood 83:691–702, 1994. 1112. Shen Y, et al: Requirement of leucine-rich repeats of glycoprotein (GP) Ibalpha for
1081. Himmelfarb J, et al: Elevated plasma glycocalicin levels and decreased ristocetin-in- shear-dependent and static binding of von Willebrand factor to the platelet membrane
duced platelet agglutination in hemodialysis patients. Am J Kidney Dis 32(1):132–138, GP Ib-IX-V complex. Blood 95(3):903–910, 2000.
1998. 1113. Springer TA, von Willebrand factor, Jedi knight of the bloodstream. Blood
1082. Kunishima S, et al: Rapid detection of plasma glycocalicin by a latex agglutination test. 124(9):1412–1425, 2014.
A useful adjunct in the differential diagnosis of thrombocytopenia. Am J Clin Pathol 1114. Tang J, et al: Mutation in the leucine-rich repeat C-flanking region of platelet glyco-
100(5):579–584, 1993. protein Ibbeta impairs assembly of von Willebrand factor receptor. Thromb Haemost
1083. Kurata Y, et al: Diagnostic value of tests for reticulated platelets, plasma glyco- 92(1):75–88, 2004.
calicin, and thrombopoietin levels for discriminating between hyperdestructive and 1115. Berndt MC, et al: Identification of aspartic acid 514 through glutamic acid 542 as a
hypoplastic thrombocytopenia. Am J Clin Pathol 115(5):656–664, 2001. glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor.
1084. Steffan A, et al: Glycocalicin in the diagnosis and management of immune thrombo- Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin. Bio-
cytopenia. Eur J Haematol 61(2):77–83, 1998. chemistry 31(45):11144–11151, 1992.
1085. Steinberg MH, Kelton JG, Coller BS: Plasma glycocalicin. An aid in the classification 1116. Coller BS: Platelet von Willebrand factor interactions, in Platelet Glycoproteins, edited
of thrombocytopenic disorders. N Engl J Med 317(17):1037–1042, 1987. by J George, D Phillips, A Nurden, pp 215–244. Plenum, New York, 1985.
1086. Kalomiris EL, Coller BS: Thiol-specific probes indicate that the alpha chain of plate- 1117. Papi M, et al: Ristocetin-induced self-aggregation of von Willebrand factor. Eur Bio-
let glycoprotein Ib is a transmembrane protein with a reactive endofacial sulfhydryl phys J 39(12):1597–1603, 2010.
group. Biochemistry 24:5430–5436, 1985. 1118. Scott JP, Montgomery RR, Retzinger GS: Dimeric ristocetin flocculates proteins, binds
1087. Muszbek L, Laposata M: Glycoprotein Ib and glycoprotein IX in human platelets to platelets, mediates von Willebrand factor-dependent agglutination of platelets. J
are acylated with palmitic acid through thioester linkages. J Biol Chem 264(17): Biol Chem 266(13):8149–8155, 1991.
9716–9719, 1989. 1119. Andrews RK, et al: Purification of botrocetin from Bothrops jararaca venom. Analysis
1088. Du X, Fox JE, Pei S: Identification of a binding sequence for the 14–3-3 protein within of the botrocetin-mediated interaction between von Willebrand factor and the human
the cytoplasmic domain of the adhesion receptor, platelet glycoprotein Ib alpha. J Biol platelet membrane glycoprotein Ib-IX complex. Biochemistry 28(21):8317–8326, 1989.
Chem 271(13):7362–7367, 1996. 1120. Olson JD, et al: Adhesion of platelets to purified solid-phase von Willebrand factor:
1089. Andrews RK, et al: Binding of purified 14–3–3 zeta signaling protein to discrete Effect of wall shear rate, ADP, thrombin, and ristocetin. J Lab Clin Med 114:6–18,
amino acid sequences within the cytoplasmic domain of the platelet membrane glyco- 1989.
protein Ib-IX-V complex. Biochemistry 37(2):638–647, 1998. 1121. Ruggeri ZM, Von Willebrand factor, platelets and endothelial cell interactions. J
1090. Calverley DC, Kavanagh TJ, Roth GJ: Human signaling protein 14–3–3zeta interacts Thromb Haemost 1(7):1335–1342, 2003.
with platelet glycoprotein Ib subunits Ibalpha and Ibbeta. Blood 91(4):1295–1303, 1998. 1122. Sixma JJ: Interaction of blood platelets with the vessel wall, in Haemostasis and Throm-
1091. Wardell MR, et al: Platelet glycoprotein Ib beta is phosphorylated on serine 166 by bosis, edited by AL Bloom, CD Forbes, DP Thomas, EGD Tuddenham, pp 259–285.
cyclic AMP-dependent protein kinase. J Biol Chem 264(26):15656–15661, 1989. Churchill Livingstone, London, England, 1994.
1092. Andrews RK, Fox JE: Identification of a region in the cytoplasmic domain of the 1123. Parker RI, Gralnick HR: Fibrin monomer induces binding of endogenous VWF to the
platelet membrane glycoprotein Ib-IX complex that binds to purified actin- binding glycocalicin portion of platelet glycoprotein Ib. Blood 70:1589–1594, 1987.
protein. J Biol Chem 267(26):18605–18611, 1992. 1124. Sakariassen KS, et al: Role of platelet membrane glycoproteins and von Willebrand
1093. Andrews RK, et al: The glycoprotein Ib-IX-V complex in platelet adhesion and signal- factor in adhesion of platelets to subendothelium and collagen. Ann N Y Acad Sci
ing. Thromb Haemost 82:357–364, 1999. 516:52–65, 1987.
1094. Falet H: New insights into the versatile roles of platelet FlnA. Platelets 24(1):1–5, 2013. 1125. Sakariassen KS, et al: The role of platelet membrane glycoproteins Ib and IIb-IIIa in
1095. Kanaji T, et al: GPIbalpha regulates platelet size by controlling the subcellular localiza- platelet adherence to human artery subendothelium. Br J Haematol 63:681–691, 1986.
tion of filamin. Blood 119(12):2906–2913, 2012. 1126. Ikeda Y, et al: Importance of fibrinogen and platelet membrane glycoprotein IIb/IIIa
1096. Coller BS: Inhibition of von Willebrand factor-dependent platelet function by in shear-induced platelet aggregation. Thromb Res 51:157–163, 1988.
increased platelet cyclic AMP and its prevention by cytoskeleton-disrupting agents. 1127. Siediecki CA, et al: Shear-dependent changes in the three-dimensional structure of
Blood 57:846–855, 1981. human von Willebrand factor. Blood 88(8):2939–2950, 1996.
1097. Coller BS: Effects of tertiary amine local anesthetics on von Willebrand factor-depen- 1128. Yago T, et al: Platelet glycoprotein Ibalpha forms catch bonds with human WT VWF
dent platelet function: Alteration of membrane reactivity and degradation of GPIb by but not with type 2B von Willebrand disease VWF. J Clin Invest 118(9):3195–3207,
a calcium-dependent protease(s). Blood 248:1355–1357, 1982. 2008.

Kaushansky_chapter 112_p1829-1914.indd 1902 17/09/15 3:30 pm